Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Porter

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
Applied Optics|January 7, 2017
Remote Raman measurements of minerals, organics, and inorganics at 430  m rangeTayro E Acosta-Maeda, Anupam K Misra, Lloyd G Muzangwa, et al.
Orphanet Journal of Rare Diseases|November 26, 2025
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a studyAntonis Kattamis, Ali Taher, Vip Viprakasit, et al.
Pharmaceutical Research|September 24, 2020
A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing VehiclesErik Wollmer, Frank Karkossa, Lisa Freerks, et al.
Blood|September 3, 2017
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelatorEvangelia Vlachodimitropoulou, Yu-Lin Chen, Maciej Garbowski, et al.
British Journal of Haematology|April 29, 2020
De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromesSally Killick, Aimee Jackson, Helen C Coulthard, et al.
Clinical Practice and Cases in Emergency Medicine|February 10, 2026
Phantom Arm Pain and Tinnitus in a Patient with ST-Segment Elevation Myocardial Infarction: A Case ReportJohn Porter, Chad P Liedl, Kevin P Steever, et al.
Expert Review of Hematology|July 29, 2021
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical developmentJohn Porter, Ali Taher, Vip Viprakasit, et al.
Health Education Research|October 3, 2009
Process evaluation of the Intervention with Microfinance for AIDS and Gender Equity (IMAGE) in rural South AfricaJames Hargreaves, Abigail Hatcher, Vicki Strange, et al.
Clinical Endocrinology|August 18, 2017
Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiencyUta Neumann, Martin J Whitaker, Susanna Wiegand, et al.
Haematologica|May 4, 2006
Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasiaDavid Bowen, Ann Hyslop, Norene Keenan, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
Applied Optics|January 7, 2017
Remote Raman measurements of minerals, organics, and inorganics at 430  m rangeTayro E Acosta-Maeda, Anupam K Misra, Lloyd G Muzangwa, et al.
Orphanet Journal of Rare Diseases|November 26, 2025
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a studyAntonis Kattamis, Ali Taher, Vip Viprakasit, et al.
Pharmaceutical Research|September 24, 2020
A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing VehiclesErik Wollmer, Frank Karkossa, Lisa Freerks, et al.
Blood|September 3, 2017
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelatorEvangelia Vlachodimitropoulou, Yu-Lin Chen, Maciej Garbowski, et al.
British Journal of Haematology|April 29, 2020
De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromesSally Killick, Aimee Jackson, Helen C Coulthard, et al.
Clinical Practice and Cases in Emergency Medicine|February 10, 2026
Phantom Arm Pain and Tinnitus in a Patient with ST-Segment Elevation Myocardial Infarction: A Case ReportJohn Porter, Chad P Liedl, Kevin P Steever, et al.
Expert Review of Hematology|July 29, 2021
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical developmentJohn Porter, Ali Taher, Vip Viprakasit, et al.
Health Education Research|October 3, 2009
Process evaluation of the Intervention with Microfinance for AIDS and Gender Equity (IMAGE) in rural South AfricaJames Hargreaves, Abigail Hatcher, Vicki Strange, et al.
Clinical Endocrinology|August 18, 2017
Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiencyUta Neumann, Martin J Whitaker, Susanna Wiegand, et al.
Haematologica|May 4, 2006
Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasiaDavid Bowen, Ann Hyslop, Norene Keenan, et al.
Pageof 16